Background-Positive arterial remodeling and thin fibrous cap are characteristics of rupture-prone or vulnerable plaque.
P revious pathological and clinical studies have suggested that positive arterial remodeling is an adaptive vessel response to accommodate for atherosclerotic plaque accumulation and, thus, prevents luminal narrowing. [1] [2] [3] [4] On the other hand, positive arterial remodeling also is known as one of the morphological characteristics of vulnerable plaque. Several studies have shown consistently that positive remodeling is a predominant pattern of arterial remodeling observed in patients with acute coronary syndrome. [5] [6] [7] Although it has been reported that both positive remodeling and plaque rupture could be caused by degradation of the extracellular matrix by matrix metalloproteinases, 8 -11 serial vessel behavior of the coronary artery and fibrous cap and the relationship between arterial remodeling and changes in fibrous cap thickness have not been investigated because a single intracoronary imaging modality is not capable of providing both entire vessel configuration and changes in thin fibrous cap.
Clinical Perspective on p 490
We hypothesized that arterial remodeling (ie, serial changes in vessel size) and changes in fibrous cap thickness may be associated with each other. Therefore, we conducted serial (baseline and 6-month) intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging of nonostial, nontarget, intermediate coronary lesions and investigated the relationship between arterial and fibrous cap remodeling.
Methods

Study Population and Percutaneous Coronary Intervention Procedures
A total of 36 patients (24 men; mean age, 70Ϯ8 years) with ischemic heart disease who underwent preintervention IVUS and OCT imaging of the 3 epicardial coronary vessels were enrolled in this study. Patients with acute myocardial infarction, chronic total occlusion, left main disease, ostial lesion, heavily calcified lesion, tortuous lesion, and chronic renal failure (serum creatinine Ն2.5 mg/dL) were excluded. This study was in compliance with the Declaration of Helsinki with regard to investigations in humans, and the study protocol was approved by the Ethics Committee of Kawasaki Medical School Hospital (Kurashiki, Japan). Written informed consent was obtained from all patients before cardiac catheterization.
Coronary angiography was performed after intracoronary injection of nitroglycerin (250 g) or isosorbide dinitrate (1 mg). Dual antiplatelet therapy with aspirin (100 mg daily) and ticlopidine (200 mg daily) or clopidogrel (75 mg daily) was started before stent deployment and continued for at least 12 months. Cardiac catheterization was performed by radial or femoral approach using a 6-F guiding catheter. Percutaneous coronary intervention (PCI) was performed to treat culprit lesions. After successful PCI, both IVUS and OCT were performed in all 3 coronary arteries.
Study segments were selected based on the outcomes from angiography, IVUS, and OCT as follows: (1) angiographic diameter stenosis between 25% to 75%, (2) plaque burden Ͼ40% by IVUS, 12, 13 and (3) presence of fibroatheroma by OCT. The fibroatheroma was defined as lipid-rich plaque in Ͼ1 quadrant that has lipid, as previously reported. 14, 15 The arc of the lipid-rich plaque was measured from the lumen center ( Figure 1 ). By OCT, plaques were classified into 3 types-fibrous, fibrocalcific, and lipid rich-as previously reported. 15, 16 In brief, lipid-rich plaque was defined as signal-poor regions with diffuse borders; fibrous plaque was defined as homogeneous, signal-rich regions; and fibrocalcific plaque was defined as well-delineated, signal-poor regions with sharp borders. Fibrous cap was defined as the signal-rich layer from the coronary artery lumen to the inner border of the underlying lipid-rich plaque ( Figure 1 ). Two independent investigators who were unaware of clinical presentation diagnosed presence or absence of fibroatheroma. When there was discordance between them, a consensus reading was obtained. After 6 months following PCI, IVUS and OCT examinations were repeated to evaluate the serial changes in fibroatheroma.
IVUS Imaging
IVUS imaging was performed using a commercially available catheter with an automatic pullback device at 0.5 mm/s, and the data were digitized for quantitative and qualitative analysis according to the criteria of the American College of Cardiology Clinical Expert Consensus document on IVUS. 17 The acquired images were recorded on CD-ROM for offline analysis by echoPlaque software. External elastic membrane (EEM) and lumen cross-sectional area (CSA) were measured. Plaque plus media (PϩM) CSA was calculated by EEMϪlumen CSA. Percent plaque burden was calculated by (PϩM CSA/EEM CSA)ϫ100. The cross-section with the smallest lumen CSA was selected for analysis. If there were multiple cross-sections with the smallest lumen CSA, the image slice with the largest EEM and PϩM CSA equaling the largest plaque burden was analyzed. 18, 19 The identical cross-section was carefully selected using intravascular or perivascular landmarks and a constant pullback speed. 18, 19 Remodeling index was defined as EEM CSA at the target lesion divided by EEM CSA at the reference. A remodeling index Ͼ1 was defined as positive remodeling. 19 -22 Interobserver variability for EEM CSA and lumen CSA were 4.3Ϯ5.4% and 4.2Ϯ5.1%, respectively. Intraobserver variability for EEM CSA and lumen CSA were 2.8Ϯ4.9% and 2.7Ϯ5.3%, respectively.
OCT Imaging
After the IVUS procedure, OCT examination was performed as previously described. 16, [23] [24] [25] [26] The OCT system used in this study consists of an electro-optical imaging engine, a computer, 2 monitor displays, a probe interface unit, and a 0.014-in wire-type imaging catheter. The entire vessel length was imaged with an automatic pullback device at 1 mm/s, and the OCT data were recorded on a CD-ROM for offline analysis, for which proprietary software from LightLab Imaging was used. The thickness of the fibrous cap was measured 3 times, and its average was defined as the minimum distance from the coronary artery lumen to inner border of the lipid pool, which was characterized by a signal-poor region in the OCT image. 24, 27 Inter-and intraobserver variability of this measurement was 8.8Ϯ7.8% and 8.5Ϯ7.3%, respectively.
Laboratory Data
Laboratory data were obtained 24 hours before the cardiac catheterization and at 6-month follow-up.
Clinical Follow-Up
Clinical follow-up data were obtained by either a chart review or a telephone contact at 12 months after the index PCI procedure. A composite of all-cause death, acute coronary syndrome (unstable angina pectoris, non-ST elevation myocardial infarction, or ST elevation myocardial infarction) related to the analyzed segments, and revascularization of the analyzed segments was a prespecified clinical end point.
Statistical Analysis
Statistical analysis was performed with StatView version 5.0 and SPSS Statistics 18 software. Qualitative data are presented with frequencies, and quantitative data are shown as meanϮSD, if indicated. Continuous variables are reported as meanϮSD. Paired t tests were used to differentiate 2 sets of data with normal distribution. Wilcoxon signed rank test was performed when the data were not normally distributed. The association between IVUS and OCT indices was investigated with linear regression analysis. Multiple logistic regression analysis was used to determine whether baseline measures predicted fibrous cap thinning. Generalized estimating equations (GEE) modeling were performed to account for the correlation between arteries and lesions within the same patients. A PϽ0.05 was considered statistically significant.
Results
Eighty-two nonsignificant, nonculprit lesions from 108 coronary arteries were selected. Fifty-eight from the 82 lesions were diagnosed as fibroatheroma based on OCT and thus enrolled in the study (1 lesion from 27 patients, 2 lesions from 7 patients, 3 lesions from 1 patient, and 5 lesions from 1 patient).
Patient characteristics and laboratory data are shown in Tables 1 and 2, respectively. Eighteen (31%) plaques were detected in the left anterior descending artery, 8 (14%) in the left circumflex artery, and 32 (55%) in the right coronary artery. All IVUS and OCT images were acquired successfully without any complications. The interval between PCI and follow-up angiographic examination was 209Ϯ51 days. During the follow-up period, dual antiplatelet therapy with use of aspirin and thienopyridine (ticlopidine or clopidogrel) were continued in all study patients. Statin was prescribed in 69%. Ten patients with baseline low-density lipoprotein (LDL) cholesterol level Ͻ100 mg/dL were not treated with statin. Angiotensin-converting enzyme inhibiter or angiotensin receptor blocker was used in 64% of the study patients.
IVUS and OCT Analysis
The total length of the coronary arteries examined by both IVUS and OCT was 54Ϯ18 mm in the left anterior descending artery, 58Ϯ10 mm in the left circumflex artery, and 69Ϯ12 mm in the right coronary artery.
Baseline and follow-up quantitative IVUS and OCT results are summarized in Table 3 . Overall, EEM CSA, lumen CSA, PϩM CSA, plaque burden, and remodeling index by IVUS did not change over time (all P values nonsignificant). Similarly, fibrous cap thickness and the arc of the lipid-rich plaque did not change significantly during follow-up (all P values nonsignificant).
Percent changes (%⌬) in lumen CSA correlated positively (rϭ0.48; Pϭ0.0001; GEE adjusted, rϭ0.58; PϽ0.001) with %⌬EEM CSA (Figure 2 ), concordant with previous reports. 18, 19 On the other hand, %⌬PϩM CSA did not correlate (rϭϪ0.23; Pϭ0.08; GEE adjusted, rϭϪ0.05; Pϭ0.74) with the %⌬lumen CSA (Figure 3 ), also concordant with previous reports and suggesting that arterial remodeling rather than plaque change contributed to the luminal expansion or narrowing during the follow-up.
Percent change in fibrous cap thickness [%⌬ cap thicknessϭ100ϫ(fibrous cap thickness at follow-upϪfibrous cap thickness at baseline)/fibrous cap thickness at baseline] by OCT correlated negatively and significantly (rϭϪ0.54; Figure 4B ). Figure 5 is a representative case that shows positive remodeling and fibrous cap thinning during 6-month follow-up. Baseline LDL cholesterol (rϭ0.01; Pϭ0.91), baseline C-reactive protein (rϭ0.08; Pϭ0.53), ⌬LDL cholesterol (rϭ0.08; Pϭ0.56), and ⌬C-reactive protein (rϭ0.08; Pϭ0.55) did not correlate with %⌬cap thickness. By multiple logistic regression analysis, no baseline IVUS indices predicted fibrous cap thinning (%⌬ cap thickness Ͻ0%) during 6 months.
Clinical Follow-Up
At 12-month follow-up, no death was documented. Acute coronary syndrome related to the analyzed segments and revascularizations of the analyzed segments were observed in 2 (6%) patients. As a result, a composite end point was documented in 2 (6%) patients.
Discussion
The principal finding of this study is that arterial remodeling and serial changes in fibrous cap thickness are related.
Fibrous cap thickness of the lesions with subsequent positive arterial remodeling decreased, and that with subsequent negative remodeling increased over time.
Pathological as well as serial IVUS studies have shown that positive arterial remodeling is an adaptive vascular response to accommodate for plaque accumulation. [1] [2] [3] [4] 28 Lack of this adaptive process may be associated with atherosclerotic lesion progression 29, 30 or restenosis after balloon angioplasty. 18 On the other hand, negative (inadequate) arterial remodeling or vessel shrinkage is associated with lumen narrowing in a majority of patients with stable angina pectoris. [5] [6] [7] 28, 31 Although the exact mechanism for extent and direction of arterial remodeling is not fully understood, it is suggested that intraplaque cytokines such as matrix metalloproteinases may cause disruption of the media and induce subsequent positive arterial remodeling. 9, 10 On the other hand, it also is reported that matrix metalloproteinases may cause thinning and ultimate disruption of the fibrous cap, resulting in plaque rupture and acute coronary syndrome or sudden cardiac death. 8, 11, [32] [33] [34] Therefore, our results showing that positive remodeling was associated with fibrous cap thinning are quite reasonable, considering the effect of matrix metalloproteinases. Although our results did not indicate the direct relationship between specific cytokines and arterial remodeling or fibrous cap remodeling, they did confirm the relationship between plaque accumulation and positive arterial remodeling or fibrous cap thinning. Because those plaques that increased during the 6-month follow-up may be biologically active, it is possible that soluble factors from such an active or "hot" plaque affected both arterial and fibrous cap remodeling.
IVUS and OCT studies have shown that positive arterial remodeling is related to unstable clinical presentation, increased arterial distensibility, and systemic inflammation. [5] [6] [7] 28, 35, 36 Furthermore, previous IVUS studies have consistently demonstrated that lesions with positive remodeling were associated with worse clinical outcomes. 15,19,36 -40 In our present study population, 12-month clinical follow-up did not show any prognostic impact of the arterial and fibrous cap remodeling because of the small sample size and short follow-up period. A larger study population with longer follow-up needs to be investigated to clarify the impact of serial arterial remodeling and changes in fibrous cap on long-term clinical outcomes.
A previous nonrandomized study showed that fibrous cap thickness increased over time more significantly in patients treated with statin. 27 However, the present study did not find a relationship between statin treatment and the change of fibrous cap thickness (statin group, 11.9Ϯ53.7%; nonstatin group, Ϫ0.4Ϯ46.7%; Pϭ0.28). One of the reasons might be the difference in patient characteristics. In our study population, statin was used only in patients with hyperlipidemia. Therefore, patients not on statins may have a better baseline lipid profile than those on statins. Furthermore, it is possible that the lack of association of statin use with change in cap thickness might represent a type II error. Further randomized study is needed to address the impact of aggressive lipidlowering treatment and plaque stabilization assessed by OCT.
Clinical Implications
The present study results together with those of previous reports showing that both thin fibrous cap and positive arterial remodeling are morphological findings of vulnerable plaque have important clinical implications. Although predictors and the prognostic role of serial fibrous cap thinning associated with positive arterial remodeling have not been elucidated in this study, future study with a larger population will clarify its clinical impact. Furthermore, it would be quite interesting to investigate whether specific medications or local intervention can modify arterial and fibrous cap remodeling. Thus, positive remodeling and fibrous cap thinning can be surrogate end points of such medical or interventional treatments.
Limitations
Our study was limited by its small sample size and a lack of longer-term clinical follow-up. Because we used a currently available OCT system, which requires balloon occlusion, the ostial part of each coronary artery could not be imaged and assessed.
Another limitation is possible selection bias. Because IVUS cannot cross the severely stenotic lesions, those lesions with a diameter stenosis Ͼ75% were excluded from this study. Therefore, our results may not be generalizable to such severely stenotic lesions.
Finally, plaque characterization (signal rich or signal poor) of the OCT images was based on visual interpretation, which sometimes can be subjective. To provide objective and quantitative measures of the plaque characterization, signal intensity of the visually diagnosed lipid-rich plaque also can be measured by Scion image software. Signal intensity of the visually diagnosed lipid-rich plaques was well below a cut-off value to differentiate lipid from fibrous plaque (unpublished data).
Conclusions
Serial IVUS and OCT examinations demonstrate that positive arterial remodeling is not only an adaptive process, but also related to thinning of the fibrous cap.
